Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Mar 27, 2025; 17(3): 100951
Published online Mar 27, 2025. doi: 10.4240/wjgs.v17.i3.100951
Published online Mar 27, 2025. doi: 10.4240/wjgs.v17.i3.100951
Figure 1 Imaging of liver and lung during different periods.
A: Radiologic assessments showed a partial response based on the modified Response Evaluation Criteria in Solid Tumors criteria; B: Computed tomography imaging examination indicated multiple metastatic sites in the lung on February 23, 2024. mRECIST: Modified Response Evaluation Criteria in Solid Tumors; PR: Partial response; SD: Stable disease.
- Citation: Wang CD, Liu RD, Liu MJ, Song J. Lung metastasis following temporary discontinuation of lenvatinib and tislelizumab in hepatocellular carcinoma: A case report. World J Gastrointest Surg 2025; 17(3): 100951
- URL: https://www.wjgnet.com/1948-9366/full/v17/i3/100951.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i3.100951